{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:07:15Z","timestamp":1790381235867,"version":"4.1.0"},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"4","content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0018907","type":"journal-article","created":{"date-parts":[[2011,4,25]],"date-time":"2011-04-25T20:52:59Z","timestamp":1303764779000},"page":"e18907","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":126,"title":["Th17 Cells and Activated Dendritic Cells Are Increased in Vitiligo Lesions"],"prefix":"10.1371","volume":"6","author":[{"given":"Claire Q. F.","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres E.","family":"Cruz-Inigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judilyn","family":"Fuentes-Duculan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariush","family":"Moussai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Sullivan-Whalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Gilleaudeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jules A.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,4,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/archderm.1977.01640010049006","article-title":"Prevalence of vitiligo. Epidemiological survey on the Isle of Bornholm, Denmark.","volume":"113","author":"J Howitz","year":"1977","journal-title":"Arch Dermatol"},{"key":"ref2","first-page":"160","article-title":"Clinical practice. Vitiligo.","volume":"360","author":"A Taieb","year":"2009","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.4049\/jimmunol.177.5.3055","article-title":"CD4 T cell-dependent autoimmunity against a melanocyte neoantigen induces spontaneous vitiligo and depends upon Fas-Fas ligand interactions.","volume":"177","author":"T Lambe","year":"2006","journal-title":"J Immunol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.0022-202X.2004.23538.x","article-title":"Peripheral CD8+ T cell tolerance against melanocytic self-antigens in the skin is regulated in two steps by CD4+ T cells and local inflammation: implications for the pathophysiology of vitiligo.","volume":"124","author":"J Steitz","year":"2005","journal-title":"J Invest Dermatol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1034\/j.1600-0749.2003.00023.x","article-title":"Evidence for an autoimmune pathogenesis of vitiligo.","volume":"16","author":"K Ongenae","year":"2003","journal-title":"Pigment Cell Res"},{"key":"ref6","article-title":"Autoantigens in vitiligo identified by the serological selection of a phage-displayed melanocyte cDNA expression library.","author":"EA Waterman","year":"2009","journal-title":"J Invest Dermatol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.autrev.2006.03.012","article-title":"Therapeutic implications of autoimmune vitiligo T cells.","volume":"5","author":"K Oyarbide-Valencia","year":"2006","journal-title":"Autoimmun Rev"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1078\/0171-9335-00423","article-title":"Initiation and regulation of CD8+T cells recognizing melanocytic antigens in the epidermis: implications for the pathophysiology of vitiligo.","volume":"83","author":"J Steitz","year":"2004","journal-title":"Eur J Cell Biol"},{"key":"ref9","article-title":"Autoimmune Destruction of Skin Melanocytes by Perilesional T Cells from Vitiligo Patients.","author":"JG van den Boorn","year":"2009","journal-title":"J Invest Dermatol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1084\/jem.192.11.1637","article-title":"Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo.","volume":"192","author":"C Yee","year":"2000","journal-title":"J Exp Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00262-008-0506-5","article-title":"Vaccine-specific local T cell reactivity in immunotherapy-associated vitiligo in melanoma patients.","volume":"58","author":"JF Jacobs","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/01.LAB.0000069521.42488.1B","article-title":"Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo.","volume":"83","author":"A Wankowicz-Kalinska","year":"2003","journal-title":"Lab Invest"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1365-2230.2005.01987.x","article-title":"Vitiligo with inflammatory raised borders, associated with atopic dermatitis.","volume":"31","author":"K Sugita","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"ref14","first-page":"1","article-title":"Inhibition of IFN-gamma as a method of treatment of various autoimmune diseases, including skin diseases.","author":"B Skurkovich","year":"2006","journal-title":"Ernst Schering Res Found Workshop"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.clim.2009.03.522","article-title":"Breaking old paradigms: Th17 cells in autoimmune arthritis.","volume":"132","author":"A Peck","year":"2009","journal-title":"Clin Immunol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nm.1984","article-title":"Targeted depletion of lymphotoxin-alpha-expressing TH1 and TH17 cells inhibits autoimmune disease.","volume":"15","author":"EY Chiang","year":"2009","journal-title":"Nat Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.4049\/jimmunol.181.3.1908","article-title":"Th1, Th2, and Th17 effector T cell-induced autoimmune gastritis differs in pathological pattern and in susceptibility to suppression by regulatory T cells.","volume":"181","author":"GH Stummvoll","year":"2008","journal-title":"J Immunol"},{"key":"ref18","first-page":"1092","article-title":"Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways.","volume":"159","author":"KE Nograles","year":"2008","journal-title":"Br J Dermatol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/jid.2008.194","article-title":"Psoriasis is characterized by accumulation of immunostimulatory and Th1\/Th17 cell-polarizing myeloid dendritic cells.","volume":"129","author":"LC Zaba","year":"2009","journal-title":"J Invest Dermatol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jaad.2008.09.048","article-title":"The role of helper and regulatory T cells in the pathogenesis of vitiligo.","volume":"60","author":"PY Basak","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/jid.2008.225","article-title":"Resident and \u201cinflammatory\u201d dendritic cells in human skin.","volume":"129","author":"LC Zaba","year":"2009","journal-title":"J Invest Dermatol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.jid.5701213","article-title":"Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells.","volume":"128","author":"MA Lowes","year":"2008","journal-title":"J Invest Dermatol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1172\/JCI32282","article-title":"Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages.","volume":"117","author":"LC Zaba","year":"2007","journal-title":"J Clin Invest"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00403-007-0775-4","article-title":"The role of dendritic cells in the immunopathogenesis of psoriasis.","volume":"299","author":"SP Jariwala","year":"2007","journal-title":"Arch Dermatol Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.clindermatol.2007.08.012","article-title":"Immunopathogenesis and role of T cells in psoriasis.","volume":"25","author":"K Ghoreschi","year":"2007","journal-title":"Clin Dermatol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"5915","DOI":"10.1073\/pnas.93.12.5915","article-title":"Serological analysis of Melan-A(MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas.","volume":"93","author":"YT Chen","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1365-2133.1999.03002.x","article-title":"Immunohistochemistry and sentinel node biopsy in melanoma: the use of tyrosinase and Melan-A.","volume":"141","author":"P Jarrett","year":"1999","journal-title":"Br J Dermatol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1365-2559.1999.00679.x","article-title":"Melan-A\/Mart-1 expression in various melanocytic lesions and in non-melanocytic soft tissue tumours.","volume":"34","author":"Z Orosz","year":"1999","journal-title":"Histopathology"},{"key":"ref29","first-page":"1219","article-title":"Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance.","volume":"148","author":"IC Le Poole","year":"1996","journal-title":"Am J Pathol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1046\/j.1523-1747.1999.00805.x","article-title":"Accumulation of identical T cells in melanoma and vitiligo-like leukoderma.","volume":"113","author":"JC Becker","year":"1999","journal-title":"J Invest Dermatol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"19057","DOI":"10.1073\/pnas.0509736102","article-title":"Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a).","volume":"102","author":"MA Lowes","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref32","first-page":"1244","article-title":"Myeloid dendritic cells from human cutaneous squamous cell carcinoma are poor stimulators of T-cell proliferation.","volume":"123","author":"MJ Bluth","year":"2009","journal-title":"J Invest Dermatol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1084\/jem.20071094","article-title":"Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses.","volume":"204","author":"LC Zaba","year":"2007","journal-title":"J Exp Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1074-7613(04)00046-9","article-title":"NALP3 forms an IL-1\u03b2-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder.","volume":"20","author":"L Agostini","year":"2004","journal-title":"Immunity"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa061592","article-title":"NALP1 in vitiligo-associated multiple autoimmune disease.","volume":"356","author":"Y Jin","year":"2007","journal-title":"N Engl J Med"},{"key":"ref36","article-title":"Fine-mapping of vitiligo susceptibility loci on chromosomes 7 and 9 and interactions with NLRP1 (NALP1).","author":"Y Jin","year":"2009","journal-title":"J Invest Dermatol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ni1497","article-title":"Development, cytokine profile and function of human interleukin 17-producing helper T cells.","volume":"8","author":"NJ Wilson","year":"2007","journal-title":"Nat Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.4049\/jimmunol.180.3.1913","article-title":"Identification of cellular pathways of \u201ctype 1,\u201d Th17 T cells, and TNF- and inducible nitric oxide synthase-producing dendritic cells in autoimmune inflammation through pharmacogenomic study of cyclosporine A in psoriasis.","volume":"180","author":"AS Haider","year":"2008","journal-title":"J Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1087-0024.2004.00825.x","article-title":"Autoimmune aspects of depigmentation in vitiligo.","volume":"9","author":"IC Le Poole","year":"2004","journal-title":"J Investig Dermatol Symp Proc"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.","volume":"441","author":"E Bettelli","year":"2006","journal-title":"Nature"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.","volume":"6","author":"LE Harrington","year":"2005","journal-title":"Nat Immunol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/ni1496","article-title":"Interleukins 1-beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells.","volume":"8","author":"EV Acosta-Rodriguez","year":"2007","journal-title":"Nat Immunol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1056\/NEJMra0707449","article-title":"Interleukin-17 and type 17 helper T cells.","volume":"361","author":"P Miossec","year":"2009","journal-title":"N Engl J Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa062382","article-title":"A human interleukin-12\/23 monoclonal antibody for the treatment of psoriasis.","volume":"356","author":"GG Krueger","year":"2007","journal-title":"N Engl J Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1126\/science.1135245","article-title":"A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.","volume":"314","author":"RH Duerr","year":"2006","journal-title":"Science"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.21749","article-title":"Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort).","volume":"54","author":"BW Kirkham","year":"2006","journal-title":"Arthritis Rheum"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1191\/135245899678847275","article-title":"Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis.","volume":"5","author":"D Matusevicius","year":"1999","journal-title":"Mult Scler"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.jaci.2009.03.041","article-title":"IL-22-producing \u201cT22\u201d T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells.","volume":"123","author":"KE Nograles","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni0407-345","article-title":"TH-17 cells in the circle of immunity and autoimmunity.","volume":"8","author":"E Bettelli","year":"2007","journal-title":"Nat Immunol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.4049\/jimmunol.181.7.4733","article-title":"Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis.","volume":"181","author":"I Kryczek","year":"2008","journal-title":"J Immunol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1182\/blood-2007-11-120998","article-title":"Tumor-specific Th17-polarized cells eradicate large established melanoma.","volume":"112","author":"P Muranski","year":"2008","journal-title":"Blood"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1046\/j.1523-1747.2003.12368.x","article-title":"Molecular and functional bases of self-antigen recognition in long-term persistent melanocyte-specific CD8+ T cells in one vitiligo patient.","volume":"121","author":"S Mantovani","year":"2003","journal-title":"J Invest Dermatol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.coi.2007.09.002","article-title":"The inflammasome: a danger sensing complex triggering innate immunity.","volume":"19","author":"V Petrilli","year":"2007","journal-title":"Curr Opin Immunol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"R581","DOI":"10.1016\/j.cub.2005.07.049","article-title":"The inflammasome.","volume":"15","author":"V Petrilli","year":"2005","journal-title":"Curr Biol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","article-title":"TGF-\u03b2 in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.","volume":"24","author":"M Veldhoen","year":"2006","journal-title":"Immunity"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1084\/jem.20070021","article-title":"Tumoricidal activity of TLR7\/8-activated inflammatory dendritic cells.","volume":"204","author":"G Stary","year":"2007","journal-title":"J Exp Med"},{"key":"ref57","article-title":"Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production.","author":"H Fujita","year":"2009","journal-title":"Proc Natl Acad Sci"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1479-5876-5-27","article-title":"Alefacept (anti-CD2) causes a selective reduction in circulating effector memory T cells (Tem) and relative preservation of central memory T cells (Tcm) in psoriasis.","volume":"5","author":"F Chamian","year":"2007","journal-title":"J Transl Med"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.jaci.2007.03.006","article-title":"Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis.","volume":"119","author":"E Guttman-Yassky","year":"2007","journal-title":"J Allergy Clin Immunol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0018907","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T22:51:31Z","timestamp":1540335091000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0018907"}},"subtitle":[],"editor":[{"given":"Alma","family":"Zernecke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,4,25]]},"references-count":59,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2011,4,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0018907","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,25]]}}}